Annexon, Inc. (ANNX) has 17 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Satter Muneer A mit 9,306,024 Aktien. Weitere bedeutende Anteilseigner sind Bain Capital Life Sciences Investors, LLC und Love Douglas.
In den letzten 12 Monaten haben Insider 40 Transaktionen in ANNX Aktien getätigt — 27 Käufe (im Wert von $16.29M) und 13 Verkäufe (im Wert von $321.42K). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
ANNX Insider-Beteiligungen
Größter Aktionär
Satter Muneer A
9,306,024 Aktien
Käufe (12 Monate)
27
$16.29M Wert
Verkäufe (12 Monate)
13
$321.42K Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Satter Muneer A |
Director |
9,306,024 |
2025-11-21 |
|
| 2 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
5,401,926 |
2023-05-30 |
|
| 3 |
Love Douglas |
President and CEO |
1,250,000 |
2026-02-23 |
|
| 4 |
Overdorf Michael |
EVP & Chief Business Officer |
182,625 |
2026-03-04 |
|
| 5 |
Artis Dean Richard |
EVP & Chief Scientific Officer |
180,093 |
2026-03-04 |
|
| 6 |
Lew Jennifer |
EVP & Chief Financial Officer |
170,700 |
2026-03-04 |
|
| 7 |
Yednock Ted |
EVP & Chief Innovation Officer |
154,161 |
2026-03-04 |
|
| 8 |
Dananberg Jamie |
Chief Medical Officer |
123,582 |
2026-03-04 |
|
| 9 |
Carson William H. |
Director |
62,405 |
2026-03-12 |
|
| 10 |
Wiggans Thomas G |
Director |
55,000 |
2025-06-09 |
|
| 11 |
Cockroft Bettina M. |
Director |
55,000 |
2025-06-09 |
|
| 12 |
Jones William A Jr |
Director |
55,000 |
2025-06-09 |
|
| 13 |
Waddill William D. |
Director |
55,000 |
2025-06-09 |
|
| 14 |
Mattheakis Larry |
EVP & Chief Scientific Officer |
37,500 |
2022-07-13 |
|
| 15 |
Choi Jung |
Director |
33,000 |
2025-12-03 |
|
| 16 |
Keswani Sanjay |
EVP & Chief Medical Officer |
12,500 |
2022-02-15 |
|
| 17 |
Sun Ricky |
Director |
10,000 |
2021-06-04 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-10 |
Carson William H. |
Director |
Informierter Kauf |
8,000 |
$5.67 |
$45.36K |
| 2026-03-02 |
Artis Dean Richard |
EVP & Chief Scientific Officer |
Informierter Verkauf |
5,894 |
$5.43 |
$32K |
| 2026-03-02 |
Yednock Ted |
EVP & Chief Innovation Officer |
Informierter Verkauf |
5,566 |
$5.42 |
$30.17K |
| 2026-03-02 |
Overdorf Michael |
EVP & Chief Business Officer |
Informierter Verkauf |
4,339 |
$5.42 |
$23.52K |
| 2026-03-02 |
Dananberg Jamie |
Chief Medical Officer |
Informierter Verkauf |
5,820 |
$5.43 |
$31.6K |
| 2026-03-02 |
Lew Jennifer |
EVP & Chief Financial Officer |
Informierter Verkauf |
5,565 |
$5.42 |
$30.16K |
| 2026-02-19 |
Artis Dean Richard |
EVP & Chief Scientific Officer |
RSU-Zuteilung |
62,500 |
- |
- |
| 2026-02-19 |
Yednock Ted |
EVP & Chief Innovation Officer |
RSU-Zuteilung |
62,500 |
- |
- |
| 2026-02-19 |
Overdorf Michael |
EVP & Chief Business Officer |
RSU-Zuteilung |
62,500 |
- |
- |
| 2026-02-19 |
Love Douglas |
President and CEO |
RSU-Zuteilung |
1,250,000 |
$5.10 |
$6.38M |
| 2026-02-19 |
Dananberg Jamie |
Chief Medical Officer |
RSU-Zuteilung |
56,250 |
- |
- |
| 2026-02-19 |
Lew Jennifer |
EVP & Chief Financial Officer |
RSU-Zuteilung |
62,500 |
- |
- |
| 2026-02-18 |
Artis Dean Richard |
EVP & Chief Scientific Officer |
Informierter Verkauf |
5,290 |
$5.10 |
$26.98K |
| 2026-02-18 |
Yednock Ted |
EVP & Chief Innovation Officer |
Informierter Verkauf |
7,857 |
$5.11 |
$40.15K |
| 2026-02-18 |
Overdorf Michael |
EVP & Chief Business Officer |
Informierter Verkauf |
6,225 |
$5.10 |
$31.75K |
| 2026-02-18 |
Dananberg Jamie |
Chief Medical Officer |
Informierter Verkauf |
5,290 |
$5.10 |
$26.98K |
| 2026-02-18 |
Lew Jennifer |
EVP & Chief Financial Officer |
Informierter Verkauf |
7,851 |
$5.11 |
$40.12K |
| 2025-12-30 |
Carson William H. |
Director |
Informierter Kauf |
4,115 |
$5.02 |
$20.66K |
| 2025-12-01 |
Carson William H. |
Director |
Informierter Kauf |
4,115 |
$4.47 |
$18.39K |
| 2025-12-01 |
Choi Jung |
Director |
Informierter Kauf |
33,000 |
$4.19 |
$138.27K |
| 2025-11-21 |
Satter Muneer A |
Director |
Informierter Kauf |
422,613 |
$4.28 |
$1.81M |
| 2025-11-20 |
Satter Muneer A |
Director |
Informierter Kauf |
400,000 |
$4.48 |
$1.79M |
| 2025-11-19 |
Satter Muneer A |
Director |
Informierter Kauf |
500,000 |
$3.94 |
$1.97M |
| 2025-11-18 |
Satter Muneer A |
Director |
Informierter Kauf |
500,000 |
$3.18 |
$1.59M |
| 2025-11-17 |
Satter Muneer A |
Director |
Informierter Kauf |
500,000 |
$2.99 |
$1.5M |
